[1]
W. Halim, B. G. de Liyis, and C. I. I. D. Sukawati, “Role of Rho-kinase Inhibitor and hrsACE2 in COVID-19 Patients Management”, nsmc, vol. 5, no. 1, pp. 63-69, Apr. 2022.